Treatments in Development for Uveitis:
Do We Have Hope?

Jointly presented by the University of Nebraska Medical Center and ASiM.

Supported by an educational grant from Allergan, Inc.

Uveitis is a multifactorial disorder that affects a wide range of patients who are typically between ages 20 and 60, and more than a quarter of these patients have a systemic disease connection. The difficulty in determining the cause and appropriate treatment regimens has led many ophthalmologists to refer these difficult cases to treatment specialists. Various common therapies include corticosteroids, nonsteroidal anti-inflammatory drugs, or immunomodulatory therapy, but for cases of noninfectious posterior uveitis, some clinicians believe that sustained-release implants present a lower risk profile. Given the numerous clinical studies under way, clinicians have more in their armamentarium than ever before to treat and manage their patients with uveitis, with or without associations of underlying systemic diseases. As a percentage of patients may not be properly managed, new avenues are welcomed, and assistance with aggregating, interpreting, and applying the new data to clinical practice, is warranted.

The goal of this activity is to provide participants with the most current clinical information on the diagnosis and management of patients with uveitis.

After completing this activity, the participant should be better able to:
  • DESCRIBE potential new treatments for uveitis based on recent research and ongoing clinical studies.
  • ASSESS the role of immunomodulatory therapy for patients with uveitis requiring long-term therapy.

This activity is designed for uveitis and retina specialists. No prerequisites required.

Quan Dong Nguyen, MD, MSc
McGaw Memorial Endowed Chair in Ophthalmology
Professor and Chairman
Inaugural Director of the Stanley M. Truhlsen Eye Institute
University of Nebraska Medical Center
Omaha, Nebraska

The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Nebraska Medical Center, Center for Continuing Education designates each enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

After reviewing this online activity, participants may receive a certificate by receiving a score of 70% or higher on the CME test and completing an evaluation. If participants score less than 70% on the CME test, they will be allowed to complete the examination 2 more times.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the UNMC Center for Continuing Education and ASiM.

The University of Nebraska Medical Center, Center for Continuing Education, presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The University of Nebraska Medical Center, Center for Continuing Education assumes no liability for the information herein.

It is the policy of The University of Nebraska Medical Center to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, and staff involved in the development of this activity have disclosed any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The intent of this disclosure is not to prevent a faculty or staff member with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The University of Nebraska Medical Center has identified and resolved any and all faculty conflicts of interest prior to the release of this activity.

Quan Dong Nguyen, MD, MSc Research funding from AbbVie, Inc, Genentech, Inc, National Eye Institute, Regeneron Pharmaceuticals, Inc, Research to Prevent Blindness, Santen Pharmaceutical Co, Ltd, and XOMA Corporation; scientific advisory board for Bausch & Lomb Incorporated, Genentech, Inc, Santen Pharmaceutical Co, Ltd, and Regeneron Pharmaceuticals, Inc; and Steering Committee for AbbVie, Inc.

The planners or other members at The University of Nebraska Medical Center, Center for Continuing Medical Education, who control content have no relevant financial relationships to disclose.

The estimated time to complete this activity: 60 minutes

Release date: May 30, 2014. Expiration date: May 30, 2015.

For the University of Nebraska Medical Center privacy policy, please click here.

Pentium 800 processor or greater, Windows 98/NT/200/XP or Mac OS 9/X or later, Microsoft Internet Explorer, Safari, Firefox, Windows Media Player 9.0 or later Flash player, 128 MB of RAM Monitor settings: High color at 800 x 600 pixels, sound card and speakers, Adobe Acrobat Reader.

Instructions: Please complete the pre-assessment for the web lecture, listen to the presentation, and complete the post-assessment and evaluation to receive CME credit. A certificate of participation will be available online immediately following successful completion of the activity.


Treatments in Development for Uveitis: Do We Have Hope?

Quan Dong Nguyen, MD, MSc


Submit a case to review at meeting:

procced to pretest

MyCMESite is published by ASiM CE, LLC, d/b/a ASiM 166 W. Main Street, Somerville, NJ 08876. (908) 253-9001. Copyright ©2017 by ASiM CE, LLC. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. ASiM is a registered trademark of ASiM CE LLC. Contact Us